Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Boehringer Ingelheim
McKinsey
Medtronic
Baxter

Last Updated: January 30, 2023

Clonazepam - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for clonazepam and what is the scope of freedom to operate?

Clonazepam is the generic ingredient in three branded drugs marketed by Alembic Pharms Ltd, Barr, Par Pharm, Sun Pharm Inds Inc, Roche, Accord Hlthcare, Actavis Elizabeth, Aurobindo Pharma Usa, Mylan Pharms Inc, Prinston Inc, Rubicon, Sandoz, Teva, Watson Labs, and Cheplapharm, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Twenty-nine suppliers are listed for this compound.

Drug Prices for clonazepam

See drug prices for clonazepam

Drug Sales Revenue Trends for clonazepam

See drug sales revenues for clonazepam

Recent Clinical Trials for clonazepam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The Medical Research NetworkPhase 4
AbbViePhase 4
All India Institute of Medical Sciences, New DelhiPhase 2/Phase 3

See all clonazepam clinical trials

Pharmacology for clonazepam
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for clonazepam

US Patents and Regulatory Information for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 078654-003 Aug 27, 2014 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Accord Hlthcare CLONAZEPAM clonazepam TABLET;ORAL 077147-001 May 2, 2005 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Par Pharm CLONAZEPAM clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 077171-003 Aug 3, 2005 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-005 Dec 23, 1997 See Plans and Pricing See Plans and Pricing
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-002 Dec 23, 1997 See Plans and Pricing See Plans and Pricing
Roche KLONOPIN RAPIDLY DISINTEGRATING clonazepam TABLET, ORALLY DISINTEGRATING;ORAL 020813-001 Dec 23, 1997 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.